---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-030962"
form_type: "8-K"
ticker: "SONM"
cik: "0001178697"
company_name: "DNA X, Inc."
filed_at: "2024-08-09T23:59:59+00:00"
generated_at: "2026-05-31T10:20:10.851166+00:00"
event_type: "earnings"
sentiment: "negative"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Sonim Q2 revenue $11.5M, net loss $6.6M; expects H2 sequential growth

## Summary
- Net revenues of $11.5M, down from $16.8M in Q1 2024.
- GAAP net loss of $6.6M included a $3.2M impairment charge; adjusted EBITDA was -$2.0M.
- Ended quarter with $9.6M cash; raised $3.85M in an above-market equity transaction.
- Began product launches with tier-one carriers; expects sequential revenue growth in Q3 and Q4.
- Secured new product awards, including a 5G variant of the XP3plus flip phone with a US tier-one carrier.

## SEC filing metadata
- accession: 0001493152-24-030962
- form_type: 8-K
- ticker: SONM
- cik: 0001178697
- company_name: DNA X, Inc.
- filed_at: 2024-08-09T23:59:59+00:00
- event_type: earnings
- sentiment: negative
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1178697/000149315224030962/0001493152-24-030962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1178697/000149315224030962/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-030962
- JSON: https://secwatch.observer/filing/0001493152-24-030962.json
- Plain text: https://secwatch.observer/filing/0001493152-24-030962.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.